Kathryn L. Zephir
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Mosquito-borne diseases and control, Malaria Research and Control, Influenza Virus Research Studies, Immunotherapy and Immune Responses, Viral Infections and Vectors
Most-Cited Works
- → Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
- → Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)374 cited
- → Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses(2019)314 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection(2017)251 cited
- → Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect(2013)131 cited
- → An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial(2017)29 cited
- → Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials(2024)18 cited
- → Correction: Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)8 cited
- → Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses(2019)5 cited